Cancer incidence after localized therapy for prostate cancer
β Scribed by Kihyuck Moon; George J. Stukenborg; Jessica Keim; Dan Theodorescu
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 304 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The results of this assessment of the literature indicated that neoadjuvant therapy followed by prostatectomy may improve longβterm outcomes for patients with highβrisk localized disease. In addition, this approach provides a paradigm for evaluating the activity and mechanism of action
W e commend Sonpavde et al 1 on their review of neoadjuvant therapy prior to prostatectomy, which focused on neoadjuvant drug trials. The bulk of preoperative intervention trials for prostate cancer utilize neoadjuvant chemotherapy, but we would like to comment on the use of preoperative radiotherap
Prostate brachytherapy is an effective treatment option for clinically organ-confined prostate carcinoma. Observed 5-and 10-year follow-up have documented prostate-specific antigen (PSA) levels that were comparable to published radical prostatectomy series and were better than several published exte